Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

0.9493 +0.0383 (+4.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen Inc

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
30 Stocks Moving in Thursday's Pre-Market Session
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 94.2% to $2.33 in pre-market trading. Stealth BioTherapeutics showcased data for Elamipretide in dry age-related... 
Via Benzinga
Why Ocugen Stock Continues to Be a Great Short Opportunity
No U.S. government official has made positive comments about approving Covaxin and the Covaxin trials do not seem to meet the FDA's preferences. OCGN stock is a short. 
Via InvestorPlace
Exposures Product Safety
Don’t Chase Ocugen Stock Without Reading the Fine Print
OCGN stock has soared on positive vaccine data. But investors must remember that Ocugen's market and experience are sharply limited. 
Via InvestorPlace
Exposures COVID-19
Ocugen Looks Perched and Ready to Blow Through $18
Ocugen had a strong April gaining a whopping 87% for the month. OCGN stock is now up 313% on the year. It seems $18 is just around the corner. 
Via InvestorPlace
Can This News Push Ocugen Ahead of Pfizer and Moderna?
Ocugen may be able to handle one of the biggest challenges facing vaccine makers. 
Via The Motley Fool
Exposures COVID-19
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Cocrystal Pharma (NASDAQ:COCP) stock rose 143.41% to $3.02 during Tuesday's regular session. Trading volume for Cocrystal Pharma's stock is 378.0 million... 
Via Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target... 
Via Benzinga
Exposures COVID-19
64 Biggest Movers From Yesterday
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7... 
Via Benzinga
2 Expensive Stocks I'd Definitely Avoid
These businesses could be in trouble once the pandemic is over. 
Via The Motley Fool
52 Biggest Movers From Yesterday
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)... 
Via Benzinga
Here's Why Ocugen Stock Soared Today
The biotech could potentially help to protect people from new coronavirus variants. 
Via The Motley Fool
Exposures COVID-19
Monday Markets Unhinged
Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan. 
Via Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Precipio (NASDAQ: 
Via Benzinga
Stick With Ocugen As Its Covid-19 Vaccine Is the Real Deal
Covid-19 vaccine candidate Covaxin may inhibit transmissions, and OCGN stock traders should appreciate the promising recent clinical results. 
Via InvestorPlace
Exposures COVID-19
Mid-Afternoon Market Update: Crude Oil Rises 1.5%; AVROBIO Shares Plummet
Toward the end of trading Monday, the Dow traded up 0.82% to 34,152.49 while the NASDAQ fell 0.36% to 13,912.07. The S&P also rose, gaining 0.41% to 4,198.29. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
2 Biopharma Stocks Looking To Make A Difference Against COVID-19: Technical Levels To Watch
Shares of Ocugen Inc. and Vaxart Inc. are moving Monday, May 3. Ocugen shares gapped higher after the company's studies showed that COVAXIN is potentially effective against three key variants of... 
Via Talk Markets
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
Here's the list of some unusual options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Precipio (NASDAQ:PRPO) stock moved upwards by 111.42% to $3.85 during Monday's regular session. The current volume of 113.0 million shares is 18552.84% of... 
Via Benzinga
2 Biopharma Stocks Looking To Make A Difference Against COVID-19: Technical Levels To Watch
Ocugen Inc. (NASDAQ: OCGN) and Vaxart Inc. (NASDAQ: VXRT) are moving Monday. Ocugen shares gapped higher after the company's studies showed that COVAXIN is potentially... 
Via Benzinga
Mid-Day Market Update: Nasdaq Drops 50 Points; Ocugen Shares Spike Higher
Midway through trading Monday, the Dow traded up 0.92% to 34,187.80 while the NASDAQ fell 0.37% to 13,910.67. The S&P also rose, gaining 0.36% to 4,196.13. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
32 Stocks Moving In Monday's Mid-Day Session
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares jumped 99.7% to $14.42 after jumping 38% on Friday. Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 30.5% to $64.... 
Via Benzinga
OCGN Stock: The Big Study News Shooting Ocugen Shares Higher Today
Ocugen (OCGN) stock is soaring on Monday after announcing positive data concerning its Covaxin vaccine candidate for the novel coronavirus. 
Via InvestorPlace
Why Ocugen Shares Are Trading Higher Today
Ocugen (NASDAQ: OCGN) shares are trading higher after the company announced studies showing COVAXIN is potentially effective against three key variants of SARS-CoV-2. In the... 
Via Benzinga
Is Now The Time To Buy Stock In Ocugen, Tilray Or Nio?
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers BioVie (NASDAQ:BIVI) shares increased by 12.96% to $19.78 during Monday's pre-market session. The company's market cap stands at $275.2 million. Ocugen (... 
Via Benzinga
Ocugen Shares Gain After Its Partner's COVID-19 Vaccine Shows Effectiveness Against Multiple Variants
Ocugen Inc (NASDAQ: OCGN) has announced that in a new study, COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2.... 
Via Benzinga
Exposures COVID-19
If You Have Ocugen Stock, Now’s the Time to Take Profits
The U.S. vaccine rollout narrative doesn’t look great for OCGN stock, so profit-taking should be considered. 
Via InvestorPlace
Exposures COVID-19
Despite Covaxin News, Ocugen Stock Remains a Long-Shot for US Use
Yet, there's little to indicate it will obtain FDA approval. In addition, there's plenty suggesting that the U.S., already oversupplied when it comes to vaccines, has little need for Covaxin. In short,... 
Via InvestorPlace
Exposures COVID-19 Product Safety
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.